1. Home
  2. MAMA vs ZURA Comparison

MAMA vs ZURA Comparison

Compare MAMA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

N/A

Current Price

$14.93

Market Cap

602.1M

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$3.66

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAMA
ZURA
Founded
2010
2022
Country
United States
United States
Employees
N/A
40
Industry
Specialty Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.1M
455.4M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
MAMA
ZURA
Price
$14.93
$3.66
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$19.00
$13.00
AVG Volume (30 Days)
471.4K
892.6K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
N/A
EPS
0.05
N/A
Revenue
$95,420,129.00
N/A
Revenue This Year
$31.09
N/A
Revenue Next Year
$16.12
N/A
P/E Ratio
$298.20
N/A
Revenue Growth
95.54
N/A
52 Week Low
$7.82
$1.00
52 Week High
$17.85
$7.25

Technical Indicators

Market Signals
Indicator
MAMA
ZURA
Relative Strength Index (RSI) 53.76 36.79
Support Level $14.26 $3.25
Resistance Level $16.19 $4.12
Average True Range (ATR) 0.78 0.24
MACD 0.03 0.01
Stochastic Oscillator 66.41 36.21

Price Performance

Historical Comparison
MAMA
ZURA

About MAMA Mama's Creations Inc.

Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: